The National Institute on Drug Abuse (NIDA) awarded a $24,999.00 firm fixed price purchase order contract to Biocytogen Boston Corp, a for-profit organization, to provide custom rat CRISPR knockout models for use in transgenic development of HIV-related rats. The contract has an ultimate completion date of December 31, 2024. Biocytogen Boston Corp is a vendor that specializes in genetically engineered animal models and has previously received contracts from federal agencies such as the...
<p>Biocytogen Boston Corporation was awarded a firm fixed price purchase order valued at thirteen thousand one hundred dollars by the National Institutes of Health's National Institute on Drug Abuse. The contract is for the delivery of FOS-T2A-ICREERT2 knockin Sprague Dawley rats to the agency's facilities in Baltimore, Maryland. No set-aside designation was applied to this procurement. Work under the contract is to be completed by February 21, 2025.</p>
This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...
This is a firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of specialized Kremen1-flox mice, which are a type of knockout mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of November 19,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185291). Under the firm fixed price contract, Cyagen Biomodels LLC will deliver conditional knockout mouse models to support the NIH's research efforts from its facility in Santa Clara, California. The contract term runs from September 6, 2023 through...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,971.50 firm fixed price purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185806). As the prime contractor, Cyagen Biomodels LLC will deliver the requested mouse models from its facility in Santa Clara, California under the terms of this contract over a six-month period concluding in March 2024. The award...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...
This is a firm-fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of conditional knockout mouse lines to support NICHD's research programs. The total ceiling value of the contract is $11,930, and the period of performance is through January 15, 2023....
This is a $50,250 fixed-price federal contract award to Taconic Biosciences, Inc. by the National Institutes of Health (NIH) for the production and delivery of specialized genetically engineered rodent models. The award is a purchase order issued under a larger $99 million Indefinite Delivery Contract (IDC) for Laboratory Animal Procurement that Taconic holds with the NIH Office of Logistics and Acquisition Operations. This IDC enables NIH institutes, including the National Institute of...